Migraine Briefs

Migraine, Post-Surgery Pain, and Re-hospitalization

Cephalalgia; ePub 2018 Jul 8; Platzbecker, at al


 

Patients with migraine undergoing surgery are at increased risk of 30-day hospital readmission due to pain, a recent study found. This hospital registry study examined 150,710 patients, aged 18 years or older, who underwent surgery with general anesthesia and mechanical ventilation between 2007 and 2015 at a tertiary care center and 2 affiliated community hospitals in Massachusetts. Researchers found:

  • Migraine was associated with an increased risk of 30-day pain-related readmission after surgery (adjusted odds ratio [OR] 1.42).
  • The association was stronger for migraine with aura (compared to migraine without aura: adjusted OR 1.69; compared to no migraine: adjusted OR 2.20).
  • The predicted adjusted risk of pain-related 30-day readmissions was 9.1 in 1000 surgical patients with migraine with aura and 5.4 in 1,000 patients with migraine without aura, compared to 4.2 in 1000 patients with no migraine.
  • Furthermore, migraine was associated with an increased risk of postsurgical 30-day readmission due to a priori defined migraine-related pain (headache or abdominal pain) (adjusted OR 1.55).

Platzbecker K, Zhang MB, Kurth T, et al. The association between migraine and hospital readmission due to pain after surgery: A hospital registry study. [Published online ahead of print July 8, 2018]. Cephalalgia. doi:10.1177/0333102418786457.

Recommended Reading

Erenumab May Control Migraines When Other Preventives Have Failed
Migraine ICYMI
Noninvasive Neurostimulator Shows Efficacy in Episodic Migraine
Migraine ICYMI
How Common Are Comorbidities in Chronic Versus Episodic Migraine?
Migraine ICYMI
Ubrogepant May Treat Acute Migraine Attacks Effectively
Migraine ICYMI
Quantitative Sensory Testing in Those with Migraine
Migraine ICYMI
Migraineurs’ Initiation of Behavioral Treatment
Migraine ICYMI
Migraineurs Have Reduced Visual Quality of Life
Migraine ICYMI
Cognitive Behavioral Therapy for Pediatric Migraine
Migraine ICYMI
Eptinezumab May Reduce Migraine Frequency in Patients With Chronic and Episodic Migraine
Migraine ICYMI
Fremanezumab May Be an Effective Preventive Treatment for Chronic Migraine
Migraine ICYMI